Functional Mutations in 5′UTR of the BMPR2 Gene Identified in Chinese Families with Pulmonary Arterial Hypertension
暂无分享,去创建一个
Nuofu Zhang | N. Zhong | Wei Wang | Chenting Zhang | Wenju Lu | Cyrus A. Hadadi | Chunli Liu | Jian Wang | Junyi Huang
[1] D. Hayes,et al. The BMPR2 missense mutation p.K230N and pulmonary arterial hypertension , 2014, Pediatric pulmonology.
[2] D. Wattanasirichaigoon,et al. 5'UTR repeat polymorphisms of the BMPR2 gene in children with pulmonary hypertension associated with congenital heart disease. , 2013, Heart, lung & circulation.
[3] Y. Mao,et al. BMPR2 Mutations Influence Phenotype More Obviously in Male Patients With Pulmonary Arterial Hypertension , 2012, Circulation. Cardiovascular genetics.
[4] J. Loyd,et al. EGR1 is essential for transcriptional regulation of BMPR2 , 2011 .
[5] P. Reynolds,et al. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension , 2011, European Respiratory Journal.
[6] Z. Jing,et al. Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients , 2011, European Respiratory Journal.
[7] Claudia Grosse,et al. CT findings in diseases associated with pulmonary hypertension: a current review. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.
[8] C. Vnencak-Jones,et al. A Novel BMPR2 Mutation Associated with Pulmonary Arterial Hypertension in an Octogenarian , 2010, Lung.
[9] G. Filippatos,et al. Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .
[10] Weili Zhang,et al. Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension , 2009, European Journal of Human Genetics.
[11] J. Cogan,et al. Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance , 2008, BMC Medical Genomics.
[12] Fen Li,et al. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension. , 2008, Chinese medical journal.
[13] M. Kramer,et al. Computed tomography angiography in pulmonary hypertension. , 2008, The Israel Medical Association journal : IMAJ.
[14] A. Sung,et al. Simvastatin enhances bone morphogenetic protein receptor type II expression. , 2006, Biochemical and biophysical research communications.
[15] L. Rubin. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[16] D. Mccrory,et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[17] W. Seeger,et al. Clinical classification of pulmonary hypertension. , 2001, Clinics in chest medicine.
[18] D. McDonald,et al. Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung. , 2003, American journal of physiology. Heart and circulatory physiology.
[19] I. Herman,et al. FGF-2 Antagonizes the TGF-β1-Mediated Induction of Pericyte α-Smooth Muscle Actin Expression: A Role for Myf-5 and Smad-Mediated Signaling Pathways , 2003 .
[20] I. Herman,et al. FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways. , 2003, Investigative ophthalmology & visual science.
[21] A. Rizzino,et al. Stimulation of the murine type II transforming growth factor‐β receptor promoter by the transcription factor Egr‐1 , 2002, Molecular reproduction and development.
[22] R. Trembath,et al. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor , 2002, Circulation.
[23] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[24] R. Trembath,et al. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.
[25] D. Marchuk,et al. Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms. , 2000, Human molecular genetics.
[26] S. Hodge,et al. Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33. , 2000, American journal of respiratory and critical care medicine.
[27] L. Gilboa,et al. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. , 2000, Molecular biology of the cell.
[28] T. Braun,et al. Alterations in somite patterning of Myf-5-deficient mice: a possible role for FGF-4 and FGF-6. , 1996, Development.
[29] A. Fine,et al. Structure and Expression of the Promoter for the Human Type II Transforming Growth Factor-β Receptor , 1994 .
[30] V. Sukhatme,et al. Mitogenic signals control translation of the early growth response gene-1 in myogenic cells. , 1994, Biochemical and biophysical research communications.
[31] A. Fine,et al. Structure and expression of the promoter for the human type II transforming growth factor-beta receptor. , 1994, Biochemical and biophysical research communications.
[32] R Wieser,et al. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region , 1993, Molecular and cellular biology.
[33] T. Braun,et al. The role of Myf-5 in somitogenesis and the development of skeletal muscles in vertebrates. , 1993, Journal of cell science.